Actio Biosciences
Actio Biosciences is a research center that develops drugs for rare diseases.
About Actio Biosciences
Actio Biosciences develops genetics-led therapies for rare and common diseases. The company applies human genetic insights and precision medicine approaches to identify drug targets and advance a pipeline including candidates for Charcot-Marie-Tooth disease type 2C (TRPV4 inhibitor ABS-0871) and KCNT1-related epilepsy (ABS-1230). It conducts preclinical and Phase 1 studies to evaluate safety, tolerability, and pharmacokinetics for its lead programs. The company also engages in collaboration, licensing, and clinical trial planning to support development and potential expansion into more common indications.
Company Facts
- Headquarters
- San Diego
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $121,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2025-06-18
- Website
- actiobiosciences.com
Industries & Categories
Bioinformatics, Biotechnology, Genetics
Social Links
Canonical: https://fsome.com/organization/actio-biosciences-49683 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.